Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SCNX Scienture Holdings, Inc.

Trading 05-06 13:15:23 EDT

0.4048

+0.0142

+3.64%

High0.4159	Low0.3880	Vol441.06K
Open0.4001	D1 Closing0.3906	Amplitude7.14%
Mkt Cap16.45M	Tradable Cap13.76M	Total Shares40.63M
T/O178.71K	T/O Rate1.30%	Tradable Shares33.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.4048,"timestamp":1778087284923,"preClose":0.3906,"halted":0,"volume":441061,"delay":0,"changeRate":0.0363543266769073,"floatShares":33992500,"shares":40630815,"eps":-2.704855,"marketStatus":"Trading","change":0.0142,"latestTime":"05-06 13:15:23 EDT","open":0.4001,"high":0.4159,"low":0.388,"amount":178711.80850515002,"amplitude":0.071429,"askPrice":0.4081,"askSize":8,"bidPrice":0.4014,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.704855,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778097600000},"marketStatusCode":2,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.3906,"preHourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.3906,"latestTime":"09:09 EDT","volume":113457,"amount":46389.68889591,"timestamp":1778072951558,"change":0.0094,"changeRate":0.024066,"amplitude":0.115207},"postHourTrading":{"tag":"盘后","latestPrice":0.382,"preClose":0.3906,"latestTime":"19:43 EDT","volume":5909,"amount":2264.8807,"timestamp":1778024583961,"change":-0.0086,"changeRate":-0.022017,"amplitude":0.022017},"volumeRatio":4.438915},"requestUrl":"/m/hq/s/SCNX/tweets","defaultTab":"tweets","newsList":[{"id":"2633387911","title":"Scienture wins third US patent for ARBLI oral suspension, protection through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2633387911","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633387911?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:10","pubTimestamp":1778069433,"startTime":"0","endTime":"0","summary":"Scienture won a third US patent covering ARBLI, a ready-to-use oral suspension of losartan potassium.USPTO issued US Patent No. 12,605,365 on April 21, 2026; protection expected to run through Oct. 7, 2041.ARBLI is positioned for US losartan market estimated at $241 million in annual sales with about 72 million prescriptions.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL7gN3KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014039.USD","BK4112","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014021.USD","LU0314104364.USD","SCNX","BK4167","IE00BN0W2V16.EUR","SG9999014013.SGD","BK4588","LU2210149790.SGD","SG9999014005.SGD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633389901","title":"Scienture Announces Third Patent Grant for Arbli™ (Losartan Potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2633389901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633389901?lang=en_us&edition=fundamental","pubTime":"2026-05-06 20:05","pubTimestamp":1778069100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA7SMFDR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632918628","title":"Scienture Holdings closes USD 11.42 million secured note financing with Streeterville Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2632918628","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632918628?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:26","pubTimestamp":1777670781,"startTime":"0","endTime":"0","summary":"Scienture Holdings closed note purchase agreement with Streeterville Capital on April 27, 2026 for two secured promissory notes totaling USD 11.42 million.Streeterville funded USD 8 million at closing; additional USD 3 million was deposited into controlled account held by wholly owned subsidiary SCNX Holdings under deposit account control agreement with Lakeside Bank.Secured Promissory Note A-1 has USD 8.42 million principal, USD 400,000 original issue discount, 9% interest; principal due 18 months from issuance.Secured Promissory Note B has USD 3 million principal, 5% interest; principal due 18 months from issuance.Terms allow monthly lender redemptions starting eight months post-close; both notes permit prepayment, including 115% premium tied to third-party refinancing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL7RnyyB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627628096","title":"Scienture granted 180-day extension to meet Nasdaq minimum bid price","url":"https://stock-news.laohu8.com/highlight/detail?id=2627628096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627628096?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:37","pubTimestamp":1776260273,"startTime":"0","endTime":"0","summary":"Scienture (SCNX) Holdings announced it received notification from Nasdaq approving the company’s request for an additional 180-calendar day extensi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-granted-180-day-extension-to-meet-nasdaq-minimum-bid-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-granted-180-day-extension-to-meet-nasdaq-minimum-bid-price-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627849792","title":"Scienture Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2627849792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627849792?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:05","pubTimestamp":1776254700,"startTime":"0","endTime":"0","summary":"COMMACK, NY, April  15, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274413/0/en/Scienture-Granted-180-Day-Extension-by-Nasdaq-to-Regain-Compliance-with-Minimum-Bid-Price-Requirement.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4167","LU2041044095.USD","A","ARB","LU0347712357.USD","LU1721428933.USD","SCNX","LU2229751404.USD","IE00BN0W2V16.EUR","LU2413666699.HKD","LU1165135440.EUR","BK4588","IE00BN0W2W23.USD","LU1543694498.USD","BK4567","LU2092937221.SGD","LU2089279066.USD","LU2413666426.HKD","IE00BN0W2T93.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625797216","title":"Scienture Provides Annual Shareholder Update, Outlining Significant Progress and Strategic Priorities for the Year Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2625797216","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625797216?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:05","pubTimestamp":1775477100,"startTime":"0","endTime":"0","summary":"COMMACK, NY, April  06, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268403/0/en/Scienture-Provides-Annual-Shareholder-Update-Outlining-Significant-Progress-and-Strategic-Priorities-for-the-Year-Ahead.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","SCNX","BK4167","BK4097","ARB","PRGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623464833","title":"BRIEF-Scienture Reports Year End 2025 Financial Results And Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623464833","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623464833?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:10","pubTimestamp":1774879819,"startTime":"0","endTime":"0","summary":"BRIEF-Scienture Reports Year End 2025 Financial Results And Provides Business UpdateMarch 30 (Reuters) - Scienture Holdings Inc SCNX.O:SCIENTURE REPORTS YEAR END 2025 FINANCIAL RESULTS AND PROVIDES BU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nTUA51DR7M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623678317","title":"Scienture FY25 operating loss widens to $42.6 million; gross margin climbs 7,240 bps to 76.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623678317","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623678317?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:10","pubTimestamp":1774872603,"startTime":"0","endTime":"0","summary":"Scienture posted a net loss of $41.5 million for 2025, swinging from net income of $9.1 million.Gross margin widened 72.4 percentage points to 76.8%.Cash and cash equivalents climbed to about $6.7 million.Management pointed to momentum for Arbli, while targeting a commercial launch of REZENOPY in Q2 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL2r50kc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2210149790.SGD","LU0314104364.USD","SG9999014039.USD","BK4167","IE00BGHQF748.EUR","LU2095319765.USD","BK4112","SG9999014021.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","SCNX","SG9999014013.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623106813","title":"SCIENTURE Reports Year End 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623106813","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623106813?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:07","pubTimestamp":1774872420,"startTime":"0","endTime":"0","summary":"Reports Significant Revenue Growth and Gross Margin Expansion in 2025 COMMACK, NY, March  30, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (“Scienture”), a holding company for exis","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/30/3264594/0/en/SCIENTURE-Reports-Year-End-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX","ARB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623594312","title":"EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2623594312","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623594312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:46","pubTimestamp":1774871167,"startTime":"0","endTime":"0","summary":"Scienture reports 216% revenue growth in 2025, driven by Arbli uptake, patent wins, and expanded healthcare access across the US.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/03/51535239/exclusive-penny-stock-scienture-reports-revenue-surge-expanding-market-access-in-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312374","title":"Scienture FY25 Revenue $431.6K Vs $136.6K YoY; Net Loss Per Common Share $(2.70) Vs $(5.41) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312374","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312374?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:45","pubTimestamp":1774871116,"startTime":"0","endTime":"0","summary":"Scienture FY25 Revenue $431.6K Vs $136.6K YoY; Net Loss Per Common Share $(2.70) Vs $(5.41) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51535218/scienture-fy25-revenue-431-6k-vs-136-6k-yoy-net-loss-per-common-share-2-70-vs-5-41-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826859","title":"Scienture Holdings Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826859","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826859?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:49","pubTimestamp":1774612144,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of28cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson March 30 (estimated) for the period ending D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F0U6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620738815","title":"Scienture Holdings Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2620738815","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620738815?lang=en_us&edition=fundamental","pubTime":"2026-03-20 19:19","pubTimestamp":1774005545,"startTime":"0","endTime":"0","summary":"Scienture Holdings Inc  expected to post a loss of28cents a share - Earnings Preview Scienture Holdings Inc SCNX.OQ SCNX.O is expected to  report resultson March 24 (estimated) for the period ending D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nL8N4080WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618928553","title":"Scienture Shares Surge 48% After Co Signs Deals to Expand Reach of Opioid Overdose Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928553?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:32","pubTimestamp":1773235940,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ1C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940746","title":"Why Is Scienture Holdings Stock (SCNX) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940746?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:15","pubTimestamp":1773234915,"startTime":"0","endTime":"0","summary":"Scienture Holdings stock rallied after the company revealed new purchase order agreements.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-scienture-holdings-stock-scnx-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-scienture-holdings-stock-scnx-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618594748","title":"Shares of Scienture up 60.1% Premarket After Co Signs Deals to Expand Reach of Opioid Overdose Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594748?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:52","pubTimestamp":1773233522,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4N3ZZ191:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618944045","title":"Scienture signs GPO agreements for REZENOPY reaching over 5,000 U.S. institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2618944045","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618944045?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:05","pubTimestamp":1773230725,"startTime":"0","endTime":"0","summary":"Scienture said it formalized multiple Group Purchasing Organization agreements for REZENOPY  Nasal Spray 10 mg. The agreements provide access to more than 5,000 U.S. healthcare institutions, including hospitals, clinics and nursing homes. Scienture said the agreements represent potential penetration into about 60% of the U.S. institutional market. The company cited IQVIA data showing the U.S. naloxone market at USD 141 million in annual sales and 9.4 million prescription units.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL42sbzB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648000940.SGD","LU0477156797.USD","LU1201861165.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4112","LU0198837287.USD","LU1989764748.USD","LU1201861249.SGD","LU2095319765.USD","LU0477156953.USD","LU1989764664.SGD","SG9999014039.USD","LU0130103400.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU0882574055.USD","BK4588","BK4530","LU1791710400.SGD","SG9999014013.SGD","LU0130517989.USD","IE00B64PRP62.GBP","LU0314104364.USD","LU0130102774.USD","LU2210149790.SGD","IQV","LU0648001328.SGD","LU1261432733.SGD","LU1791710582.SGD","BK4121","LU0130518102.USD","LU2210150020.SGD","BK4585","SCNX","NDAQ","SG9999014021.USD","BK4167","LU0980610538.SGD","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618594296","title":"SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594296","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594296?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:05","pubTimestamp":1773230700,"startTime":"0","endTime":"0","summary":"Expands institutional footprint with potential penetration of more than ~ 60% of the U.S. market, while expanding reach across EMS providers and rehabilitation centers U.S. naloxone market totals $141","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253734/0/en/SCIENTURE-Broadens-Commercial-Access-for-REZENOPY-Highest-Dose-FDA-Approved-Naloxone-Nasal-Spray-Through-GPO-Agreements-Reaching-Over-5-000-U-S-Institutions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SCNX","BK4167","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614741693","title":"Scienture Holdings Initiated at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2614741693","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614741693?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:50","pubTimestamp":1771955400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SCNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 12:50 ET (17:50 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613712681","title":"Scienture initiated with a Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2613712681","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613712681?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:33","pubTimestamp":1771940002,"startTime":"0","endTime":"0","summary":"Maxim initiated coverage of Scienture (SCNX) with a Buy rating and $1.50 price target Published first on TheFly – the ultimate source for real-time...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scienture-initiated-with-a-buy-at-maxim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scienture-initiated-with-a-buy-at-maxim-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.scientureholdings.com","stockEarnings":[{"period":"1week","weight":0.0201},{"period":"1month","weight":0.3183},{"period":"3month","weight":-0.1522},{"period":"6month","weight":-0.4778},{"period":"1year","weight":-0.5844},{"period":"ytd","weight":-0.2341}],"compareEarnings":[{"period":"1week","weight":0.017},{"period":"1month","weight":0.1036},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.0798},{"period":"1year","weight":0.2844},{"period":"ytd","weight":0.0614}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.119636},{"month":2,"riseRate":0.333333,"avgChangeRate":0.150517},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.073293},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.066727},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.098634},{"month":6,"riseRate":1,"avgChangeRate":0.56391},{"month":7,"riseRate":0.666667,"avgChangeRate":0.096061},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.16799},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.047954},{"month":10,"riseRate":0,"avgChangeRate":-0.160548},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067192},{"month":12,"riseRate":0,"avgChangeRate":-0.185859}],"exchange":"NASDAQ","name":"Scienture Holdings, Inc.","nameEN":"Scienture Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Scienture Holdings, Inc.,SCNX,Scienture Holdings, Inc.股票,Scienture Holdings, Inc.股票老虎,Scienture Holdings, Inc.股票老虎国际,Scienture Holdings, Inc.行情,Scienture Holdings, Inc.股票行情,Scienture Holdings, Inc.股价,Scienture Holdings, Inc.股市,Scienture Holdings, Inc.股票价格,Scienture Holdings, Inc.股票交易,Scienture Holdings, Inc.股票购买,Scienture Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Scienture Holdings, Inc.(SCNX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Scienture Holdings, Inc.(SCNX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction